key: cord-0751604-s6kmf6i8
authors: Altman, Carolyn A.; Donofrio, Mary T.; Arya, Bhawna; Wasserman, Melissa; Ensing, Gregory J.; Cohen, Meryl S.; Lewin, Mark B.; Swaminathan, Madhav; Barker, Piers C.A.
title: ASE Statement on Adapting Pediatric, Fetal and Congenital Heart Disease Echocardiography Services to the Evolving COVID-19 Pandemic
date: 2021-01-28
journal: J Am Soc Echocardiogr
DOI: 10.1016/j.echo.2021.01.012
sha: 282de310788ad6b6752e8e1762fb0180b3466064
doc_id: 751604
cord_uid: s6kmf6i8

nan

This statement reflects recommendations based on expert opinion, national guidelines, and available evidence. Our knowledge with regard to COVID-19 continues to evolve, as do our institutional protocols for dealing with invasive and non-invasive procedures and practice of personal protective equipment(PPE). Readers are urged to follow national guidelines and their institutional recommendations regarding best practices to protect their patients and themselves. These reports are made available by ASE as a courtesy reference source for its members. The reports contain recommendations only and should not be used as the sole basis to make medical practice decisions or for disciplinary action against any employee. The statements and recommendations contained in these reports are primarily based on the opinions of experts, rather than on scientifically-verified data. ASE makes no express or implied warranties regarding the completeness or accuracy of the information in these reports, including the warranty of merchantability or fitness for a particular purpose. In no event shall ASE be liable to you, your patients, or any other third parties for any decision made or action taken by you or such other parties in reliance on this information. Nor does your use of this information constitute the offering of medical advice by ASE or create any physician-patient relationship between ASE and your patients or anyone else. During the initial phase of the pandemic, The American Society of Echocardiography (ASE) provided guidance to our echocardiography community with "Specific Considerations for Pediatric, Fetal and Congenital Heart Disease Patients and Echocardiography Service Providers during the 2019 Novel Coronavirus Outbreak" 1 as a supplement to the broader American Society of Echocardiography statement. 2 Initial concerns that elective office visits and procedures could fuel propagation among patients, families, and providers (particularly to pregnant women and fetuses, and from asymptomatic children) along with incomplete knowledge of the best methods of mitigating transmission risk led to a dramatic reduction in echocardiography services provided to pregnant women, pediatric and congenital heart disease patients.

As the pandemic trajectory somewhat ameliorated, the ASE released the statement "Reintroduction of Echocardiography Services During the COVID-19 Pandemic" in May, 2020 to help echocardiography providers re-align practice and care. 3 In the months following these statements, we have learned much. We have observed that, typically, healthy children are less severely affected than adults during acute SARS COV-2 infection. 4 Mortality of pediatric patients requiring hospitalization is low, at approximately 0.18% 5 Socioeconomically disadvantaged and/or J o u r n a l P r e -p r o o f minority children are more likely infected, and there is increased risk of severe disease and complications in the very young or in those with chronic medical conditions. [6] [7] [8] [9] Chronic medical conditions posing additional risks in children overlap some risk factors in adults (obesity and diabetes), but diverge in others (less risk for asthma, but higher risk for neurologic, genetic, and metabolic maladies, amongst others). [8] [9] There has been obvious concern for increased risk in children with congenital heart disease because of underlying physiologic and anatomic abnormalities, yet these cases have been only rarely reported. [10] [11] Although children seem less predisposed to serious illness during the acute infection, a subset develop Multi-System Inflammatory Syndrome in Children (MIS-C) with potential accompanying hemodynamic compromise and myocardial dysfunction that may be severe enough to require support with ECMO in some cases. 12 Beyond the acute infection risks and short-term complications, the propensity of SARS-CoV-2 to injure the heart has raised concerns about the safe return of children to recreational and competitive sports. This concern has led to further debate about how best to screen children with a history of COVID 19, including whether cardiac testing should universally be performed. For fetal cardiology patients, there have been minimal nosocomial, clinic-acquired infections among pregnant patients. At the same time, pregnancy has been demonstrated to raise the risk of maternal complications from COVID-19, and there are anecdotal reports of concerning cases of critical heart disease presenting postnatally that could have been detected prenatally if typical fetal echocardiography practices had been in place. Fetal echocardiography services were not specifically addressed in the ASE Re-Introduction statement, and many practices have continued stringently to restrict access. Therefore, staged re-expansion of fetal echocardiography services is necessary to address now. In view of our improved understanding of the risks for J o u r n a l P r e -p r o o f transmission, and the differences in acute and post-infectious courses in our pediatric, congenital heart disease, and fetal cardiology patients, this statement on Adapting Pediatric, Fetal and Congenital Heart Disease Echocardiography Services to the Evolving COVID-19 Pandemic is written to update information and guidance to clinicians who provide echocardiography services.

Additional updates are provided on the impact for our sonographers and lab workflow, strategies to address trainees' education, and sedation practices.

In considering echocardiography service practice changes, readers should refer to the broader ASE Reintroduction document for Operational Considerations and Prioritization Tiers. 3 The Centers for Disease Control (CDC) has supplied Gating Criteria to be met initially and then defined four Phases of Pandemic Re-opening statewide or by community (governor prerogative), shown in Table 1 . 13 Providers should refer to the CDC for more detailed information on Gating Criteria, and take into account CDC phases, regional vaccination rates, and align with applicable state, county, or municipal mandates and public health policies.

The COVID-19 pandemic has required sonographers rapidly to change their workflow, personal safety measures, and exam protocols. The initial lockdowns decreased clinical volume so significantly that many sonographers had their hours flexed down and were at risk of being furloughed, raising personal financial stresses. Subsequently, as labs and clinics expand services, the drive to "catch up" on the accumulation of deferred exams places different physical and emotional stresses on sonographers and lab personnel. The increase in number of patients coming to the echocardiography lab is occurring concurrently with resumption of complete, comprehensive echocardiograms with longer scan times. Young children remain less compliant with facemasks and have difficulty cooperating, particularly during the long exams necessary to evaluate complex congenital heart disease. Optimal social distancing is difficult or impossible to achieve in a small echocardiography exam room with child, caretaker, and sonographer. Some sonographers considered at high-risk for COVID-19 have chosen to stay home, leaving fewer onsite sonographers to tackle an increased workload. Sonographer availability is also limited by the quarantine required when suspicious symptoms arise or a COVID-19 exposure occurs. All of these factors can lead to sonographer exhaustion and burnout, similar to what is observed in other frontline providers. To minimize this fatigue, measures to ensure appropriate patient workload and adequate rest between cases should include: 3

• Staggered scheduling with lengthened, dedicated time between echocardiography appointments • Daily and weekly rotating shift adjustments.

To maintain personal safety for sonographers, patients, families, echocardiography and clinic personnel the following measures should be employed:

• Mandatory use of masks for age appropriate patients and their caretakers at all times • Universal use of PPE (including eye protection) for the sonographer and ancillary staff (as per the "Re-Introduction Statement", the levels of PPE used will depend on the phase of the response, local institutional policies, and COVID-19 testing status.) 3

• Limiting caretakers to one individual per patient when possible Leadership decisions must be communicated to the physicians and sonographers in real-time to ensure that the teams retain confidence that their welfare and the welfare of the patients and families is the highest priority. In return, sonographers encouraging their sonographer colleagues to communicate openly regarding their physical and mental health will assist in developing strategies for coping and adjusting to evolving echocardiography lab operations.

For fetal cardiology providers, the priority at the onset of the pandemic was to minimize the exposure of pregnant women and fetuses to SARS-CoV-2. The previous ASE statement described a triaging system for scheduling fetal echocardiograms and consultations considering the risk for CHD, significant fetal arrhythmia or anomaly by referral indication while keeping in mind the scheduling limitations imposed by a finite gestational period for pregnancy decisionmaking and perinatal and neonatal management planning. 1 . This triaging system resulted in a rapid decrease in fetal cardiology visits at multiple centers (by approximately 20-35%) and decreased referrals. As a consequence, less face-to-face counseling occurred. When in-person visits did occur, they often did so with a single or even no support person accompanying the pregnant mother, even in the setting of a new diagnosis of a significant fetal congenital heart defect. Depending on local conditions, some centers began to resume more normal fetal cardiology scheduling practices and allow more support persons to accompany the patient. Re-J o u r n a l P r e -p r o o f expansion of fetal cardiology services has been highly variable, however, with some centers continuing to restrict services and see fewer referrals, with concomitant lower volumes and persistently decreased sonographer hours. Further, with rises in infection rates, other centers may reinstate more restrictive strategies.

Without question, pregnant mothers have experienced increased psychosocial stress related to regulations limiting in-person support during fetal cardiology consultations. Pregnancy itself creates a higher risk state for COVID-19-related complications. [14] [15] [16] . SARS-CoV-2 testing of pregnant women has become standard practice prior to delivery given the 10% rate of positive tests in asymptomatic women. 15, 17 . For neonates born to SARS-CoV-2 positive mothers, the greatest risks at present appear to be preterm labor and fetal distress. 18 practices. These multiple benefits will continue to be realized as a lasting approach for comprehensive fetal cardiology care after the pandemic ends.

A proposed strategy for re-expansion of fetal cardiology services adapting the previously published triage system and the CDC Pandemic Phases is delineated in Table 2 and continue to evolve as more individuals acquire immunity via disease or vaccine administration.

An algorithm for TEE procedures was outlined in the ASE guidance document for pediatric and fetal echocardiography. 1 Sedation and anesthesia personnel should continue to follow existing society guidelines and institutional protocols. 23 The risk of transmission of SARS CoV-2 from known infected patients to healthcare workers who adopt adequate precautions is low. Separate procedural rooms are recommended for patients requiring airborne isolation precautions with minimal staff for procedures with aerosolization risk such as intubation, extubation, and TEE with an unsecured airway. 24 Contact precautions (gloves, gown, facemask) may be adequate for those patients who have previously tested positive but are not considered airborne risk. 25 Additionally, standard precautions for all sedation and anesthesia requiring procedures should include gloves and facemasks at a minimum with strict attention to hand hygiene before and after the procedure.

The COVID-19 pandemic has severely impacted all aspects of medical education. The strategies implemented to adapt to this new environment have changed rapidly based on the regional prevalence of the disease and the ability to protect trainees from infection and transmission using adequate access to PPE. At the onset of the pandemic, much of the activity that was strictly educational was substantially curtailed. Fellows transitioned to frontline providers. Fellows Table 3 .

The emergence of a severe multi-system inflammatory syndrome with Kawasaki Disease (KD) or toxic shock syndrome-like features, frequent hemodynamic instability, and association with previous COVID-19 infection in otherwise previously healthy children was first reported in the United Kingdom on April 26, 2020. 26 The CDC case definition for MIS-C is provided in Table   4 . 27 In the United States as of the last update posted on the CDC on 10/30/20, there have been 1163 reported cases and 20 deaths. 28 Most children were 1-14 years of age (average 8 years), but cases were reported in infants less than 1 year of age as well. More than 75% of children were

Hispanic/Latino or Non-Hispanic Black. MIS-C in patients with known pre-existing congenital or acquired heart disease has not been reported to date. 29 Cardiac involvement may manifest in three predominant and overlapping presentations: atypical

Kawasaki-like spectrum (with particularly prominent gastrointestinal symptoms), vasodilatory/hyperinflammatory shock, or cardiogenic shock from impaired ventricular function. 29 Given the potential for pancarditis, there should be a low threshold for performing or repeating echocardiography, with indications for echocardiography outlined in Table 5 and the essential elements of an MIS-C echocardiogram presented in Table 6 .

Ventricular dysfunction may range from mild to severe. As measured by ejection fraction, 33-75% of MIS-C patients have ventricular dysfunction, with an even higher prevalence (90%) of dysfunction detected by global longitudinal strain(GLS). [29] [30] [31] [32] The right ventricle may also be affected. 33 Regional abnormalities have been noted, including apical hypokinesia resembling Takotsubo cardiomyopathy. 33 Diastolic impairment has been reported with abnormal tissue Doppler imaging (TDI). 32 Other cardiac findings have included pericardial effusion in ~8-25% of patients, mitral valve insufficiency in 50%, and greater than physiologic tricuspid valve insufficiency in 60%. 32 Coronary artery dilation has been described in 6 to 24% of patients, although true aneurysms are quite unusual. 12, [29] [30] [31] [34] [35] [36] Thrombus formation has been noted in the setting of severely depressed ventricular function, severe coronary artery dilation, or pulmonary embolism, although this complication appears to be less prevalent in MIS-C as opposed to the thromboembolic phenomena and coagulopathy reported in acute COVID infections in adults.

Serial echocardiograms are warranted during the acute illness as ventricular function can worsen precipitously in the first 24-48 hours of admission, which is often around day 7 of illness. [32] [33] Timing of studies should be guided by the clinical status in individual patients, but if ventricular dysfunction is present, repeat assessment is warranted at least every 5-7 days. 29 Fortunately, in most patients ventricular function improves after therapy and supportive care, but residual dysfunction can persist at the time of discharge, with abnormal GLS potentially persisting even after ejection fraction normalizes. 29, [32] [33] [36] [37] If coronary artery dilation is present, serial echocardiograms should be obtained following the KD guidelines. 35

Recommendations for mid-and long-term cardiac imaging are still evolving for MIS-C, depending on the clinical course, and the severity and type of residual cardiac involvement at time of discharge. Careful follow up is essential as we continue to learn more about this disease. 37, 38 One proposed strategy is for cardiology follow up with echocardiogram at 7-10 days after onset of illness, 4-6 weeks, 4-6 months, and 9-12 months. 29 More frequent follow up would be necessary if there is marked coronary dilations, again utilizing the KD guidelines. 31, 34, 35 Long-term follow up with stress echocardiography should be considered for those with chronic changes in ventricular function or coronary artery involvement.

Cardiac MRI may be useful in MIS-C patients to further quantify ventricular function, and assess for myocardial edema or scar/fibrosis. The best timing for cardiac MRI is not yet clear; however, MRI at 2-6 months in recovery could play a pivotal role in determining when MIS-C patients may safely return to active play and sports. Following KD guidelines, cardiac computed tomographic angiography (CTA) may either be useful during the acute or follow up phases to assess coronary artery involvement, progression of dilation, or suspected coronary thrombosis. 36

There is growing recognition that MIS-C includes a component of vascular injury, similar in concept if not necessarily pathophysiology to the vascular injury seen in adults with COVID-19.

However, the newness of the disease makes the long-term implications of MIS-C in children unclear. In the acute setting multiple inflammatory markers are elevated including erythrocyte sedimentation rate, C-reactive protein, ferritin, alanine aminotransferase, fibrinogen and d-dimer levels, with accompanying lymphocytopenia, neutrophilia, anemia, thrombocytopenia, hypoalbuminemia, and a prolonged international normalized ratio. 12 It remains to be seen if this widespread inflammation will permanently affect endothelial function and put these children at J o u r n a l P r e -p r o o f risk for adult cardiovascular disease over time. If MIS-C behaves in a similar fashion to KD or other inflammatory diseases, there is certainly concern for the development of accelerated atherosclerotic disease in this population. In the long-term follow up of patients affected by MIS-C, vascular function assessment such as brachial artery reactivity testing and measurement of carotid intimal-medial thickness should be considered.

Most pediatric patients with mild COVID-19 infection are asymptomatic at short term follow-up.

However, a subset may experience persistent cough, dyspnea, chest discomfort or palpitations long after resolution of acute infection. 39 The American Academy of Pediatrics (AAP) in conjunction with the CDC currently recommends that pediatricians screen children after acute COVID-19 infection for these symptoms prior to authorizing return to sports and athletics. 40 If symptoms are present, rest and referral to pediatric cardiology is recommended given the possibility that subclinical myocarditis or myocardial injury occurred during the acute illness.

Strategies for the evaluation of young athletes to determine their eligibility to return to organized sports have been proposed by the American College of Cardiology and other organizations, and include echocardiography, electrocardiography, stress testing, and possibly Cardiac MRI depending upon severity of symptoms and results of other testing. [39] [40] [41] [42] The degree of evaluation needed for children to return to physical education classes and other age appropriate activities

has not yet been established, but is likely to parallel the assessment for athletics. recommended from institution-to-institution is broad, and therefore until standardized guidelines are developed each practice must develop their own as deemed appropriate. As long-term immunity to COVID infection may not be universal, all studies should be performed using institution-specific recommendations for the patient with unknown SARS-CoV-2 status unless pre-procedure testing is obtained.

As with any new disease, the long-term course of COVID-19 and associated MIS-C is largely unknown. The above recommendations are based upon very limited short-term and mid-term data and upon our understandings of disease processes thought to be similar. We will need continued observation, meticulous investigation, creativity, and a high degree of flexibility in order to be able to provide the best patient care and effectively train our fellows and sonographers while remaining safe during this pandemic. With vaccine distribution having begun recently, we look forward to eventually moving beyond the pandemic and returning to some more normal processes. This is unlikely, unfortunately, to be in the near future as the pandemic continues to evolve with recent strong surges. Some strategies that have been developed and successfully deployed during this time should continue now and beyond the pandemic, such as telemedicine for fetal cardiology consultation and video conferences allowing readily available access to webinars, national meetings, and remote local teaching and echocardiogram review.

Reliance on the development of expert guidelines and standards, such as those developed by the ASE will be essential in order to create a safe and effective environment for staff, patients and families.

Through it all, collaboration with peers and colleagues across the country has proven to be a bedrock and essential resource for our pediatric, congenital, and fetal cardiology community. J o u r n a l P r e -p r o o f Participation of fellows and sonography students in national and international echocardiography webinars J o u r n a l P r e -p r o o f Positive for current or recent SARS-CoV-2 infection or exposure within the 4 weeks prior to the onset of symptom (noting that because infection may occur from an asymptomatic contact the child and their caregivers may not even know they had been infected) 

Specific Considerations for Pediatric, Fetal, and Congenital Heart Disease Patients and Echocardiography Service Providers during the 2019 Novel Coronavirus Outbreak: Council on Pediatric and Congenital Heart Disease Supplement to the Statement of the American Society of Echocardiography: Endorsed by the Society of Pediatric Echocardiography and the Fetal Heart Society

ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak: Endorsed by the American College of Cardiology

ASE Statement on the Reintroduction of Echocardiographic Services during the COVID-19 Pandemic

COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy

Pediatric COVID-19: Systematic review of the literature

Racial and/or Ethnic and Socioeconomic Disparities of SARS-CoV-2 Infection Among Children

Early Experience of COVID-19 in a US Children's Hospital

Assessment of 135,794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States

Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region

COVID-19 and congenital heart disease: an insight of pathophysiology and associated risks

COVID-19, State of the Adult and Pediatric Heart: From Myocardial Injury to Cardiac Effect of Potential Therapeutic Intervention. Front Cardiovasc Med

Multisystem inflammatory syndrome in U.S. children and adolescents

Activities and Initiatives Supporting the COVID-19 Response and the President's Plan for Opening America Up Again

Outcomes of Maternal-Newborn Dyads After Maternal SARS-CoV-2

Screening Maternity Populations During the COVID-19 Pandemic

Investigating the Impact of COVID-19 during Pregnancy

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery

A Systematic Review of Pregnancy and the Possibility of Vertical Transmission

Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection

Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic

American Society of Anesthesiologists Statements and Recommendations on COVID-19

A quantitative evaluation of aerosol generation during tracheal intubation and extubation

Oct 6:10. Epub ahead of print

Centers for Disease Control. Duration of Isolation and Precautions for Adults with COVID

Royal College of Paediatrics and Child Health Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease

Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States

Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARSCoV-2 epidemic: an observational cohort study

Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2

Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic

Hyperinflammatory shock in children during COVID-19 pandemic

Endocarditis, and Kawasaki Disease Committee J o u r n a l P r e -p r o o f of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the

Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 in the United States

Related Multisystem Inflammatory Syndrome in Children Affects Left Ventricular Function and Global Strain Compared with Kawasaki Disease

Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action

Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians

Clearance for Sports After COVID-19 Should Include Cardiac Screening

A Game Plan for the Resumption of Sport and Exercise After Coronavirus Disease 2019 (COVID-19) Infection. JAMA Cardiol

Returning To Play After Coronavirus Infection: Pediatric Cardiologists' Perspective